全球药品管理市场规模、份额、趋势和成长分析报告（2026-2034）

预计药品管理市场将从 2025 年的 42.5 亿美元成长到 2034 年的 107.4 亿美元，2026 年至 2034 年的复合年增长率为 10.86%。

由于全球慢性病发病率上升和老龄化社会加剧，全球药物管理市场正在迅速扩张。医疗服务提供者正在实施药物管理解决方案，以减少处方错误、提高病人安全并改善治疗效果。药物治疗的日益复杂化和多重用药的增加进一步推动了对高效药物追踪系统的需求。

关键驱动因素包括数位化医疗转型、电子健康记录（EHR）的普及以及政府主导的旨在提升病患安全标准的措施不断增加。医院和药房正在投资自动化配药系统和软体解决方案，以简化工作流程并最大限度地减少错误。远端医疗服务的扩展也推动了数位化药品管理平台的整合。

未来，人工智慧（AI）和数据分析有望在优化用药依从性和製定个人化治疗方案方面发挥关键作用。随着医疗保健系统向价值导向医疗模式转型，对智慧药物管理解决方案的需求将持续成长。技术进步和医疗费用支出的不断增加将进一步推动市场的长期扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球医药管理市场：依软体划分

• 市场分析、洞察与预测
• 电子处方笺
• 临床决策支援系统解决方案
• 库存管理软体
• 管理软体
• 自动配药系统
• 保固系统软体
• 其他软体

第五章 全球医药管理市场：依服务分类

• 市场分析、洞察与预测
• 药物分析
• 即时检验
• 药物不良反应（ADE）监测

第六章：全球药品管理市场：依交付方式划分

• 市场分析、洞察与预测
• 现场
• 基于网路的
• 基于云端的

第七章 全球医药管理市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 药局
• 其他的

第八章 全球医药管理市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Allscripts
  • QuadraMed Affinity Corporation
  • Becton
  • Cerner Corporation
  • CareFusion
  • McKesson Corporation
  • GE Healthcare
  • Omnicell Inc
  • Talyst LLC

The Medication Management Market size is expected to reach USD 10.74 Billion in 2034 from USD 4.25 Billion (2025) growing at a CAGR of 10.86% during 2026-2034.

The Global Medication Management Market is expanding rapidly due to the increasing burden of chronic diseases and the rising aging population worldwide. Healthcare providers are adopting medication management solutions to reduce prescription errors, improve patient safety, and enhance treatment outcomes. The growing complexity of drug therapies and multi-drug prescriptions has further strengthened the demand for efficient medication tracking systems.

Major drivers include digital healthcare transformation, adoption of electronic health records (EHR), and increasing government initiatives to improve patient safety standards. Hospitals and pharmacies are investing in automated dispensing systems and software solutions to streamline workflows and minimize errors. The expansion of telehealth services has also supported the integration of digital medication management platforms.

In the future, artificial intelligence and data analytics are expected to play a significant role in optimizing medication adherence and personalized treatment plans. As healthcare systems move toward value-based care, demand for smart medication management solutions will continue to grow. Technological advancements and increased healthcare spending will further support long-term market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Software

• Computerized Physician Order
• Clinical Decision Support System Solutions
• Inventory Management Software
• Administration Software
• Automated Dispensing Systems
• Assurance System Software
• Other Software

By Service

• Medication Analytics
• Point-Of-Care Verification
• ADE Surveillance

By Mode Of Delivery

• On-Premises
• Web-Based
• Cloud-Based

By End User

• Hospitals
• Pharmacy
• Others

COMPANIES PROFILED

• Allscripts, QuadraMed Affinity Corporation, Becton, Cerner Corporation, CareFusion, McKesson Corporation, GE Healthcare, Omnicell Inc, Talyst LLC
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MEDICATION MANAGEMENT MARKET: BY SOFTWARE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Software
• 4.2. Computerized Physician Order Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Clinical Decision Support System Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Inventory Management Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Administration Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Automated Dispensing Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Assurance System Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Other Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MEDICATION MANAGEMENT MARKET: BY SERVICE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Service
• 5.2. Medication Analytics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Point-Of-Care Verification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. ADE Surveillance Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MEDICATION MANAGEMENT MARKET: BY MODE OF DELIVERY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Mode Of Delivery
• 6.2. On-Premises Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Web-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cloud-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MEDICATION MANAGEMENT MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MEDICATION MANAGEMENT MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Software
  • 8.2.2 By Service
  • 8.2.3 By Mode Of Delivery
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Software
  • 8.3.2 By Service
  • 8.3.3 By Mode Of Delivery
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Software
  • 8.4.2 By Service
  • 8.4.3 By Mode Of Delivery
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Software
  • 8.5.2 By Service
  • 8.5.3 By Mode Of Delivery
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Software
  • 8.6.2 By Service
  • 8.6.3 By Mode Of Delivery
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MEDICATION MANAGEMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Allscripts
  • 10.2.2 QuadraMed Affinity Corporation
  • 10.2.3 Becton
  • 10.2.4 Cerner Corporation
  • 10.2.5 CareFusion
  • 10.2.6 McKesson Corporation
  • 10.2.7 GE Healthcare
  • 10.2.8 Omnicell Inc
  • 10.2.9 Talyst LLC